| ²é¿´: 4550 | »Ø¸´: 15 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
cambridge907½ð³æ (СÓÐÃûÆø)
|
[½»Á÷]
Cranfield´óѧ³ÏÕв©Ê¿Ñо¿Éú ÒÑÓÐ9È˲ÎÓë
|
||
|
±¾ÈËËùÔÚʵÑéÊÒµÄһλ½ÌÊÚ£¨Prof. Wang£©ÔÚÓ¢¹úCranfield´óѧ×öMarie Curie Fellow¡£ËûÏÖÔÚÕýÔÚ´úÁíһλ½ÌÊÚÕÐÒ»Ãû·Ö×ÓÓ¡¼Ç»òÓлúºÏ³É·½ÃæµÄ²©Ê¿Ñо¿Éú£¬²¢ÈÃÎÒ´úΪÔÚ¹úÄÚÐû´«¡£ÎÒÌý˵ÄÇÀïµÄ¿ÆÑÐÌõ¼þºÍ´ýÓö¶¼·ÇÒ»°ãµÄÓÅÔ½£¬¸ÐÐËȤµÄͬѧÇëÓëÍõÀÏʦÁªÏµ°¡£¡ Prof. Shenqi Wang Address: Cranfield Health, Cranfield University, Silsoe, Beds MK45 4DT, UK. Email: s.wang@cranfield.ac.uk Ðè×¼±¸µÄ²ÄÁÏ£º¸öÈËÓ¢ÎļòÀú£¨º¬»ù±¾½éÉÜ¡¢½ÌÓý¾Àú¡¢Ñо¿ÐËȤ¡¢²ÎÓëµÄÅàѵºÍ»áÒé¡¢·¢±íµÄÎÄÕºÍרÀûµÈ£©£¬Í¬Ê±×îºÃ½«·¢±íµÄÂÛÎÄÔÎĸ½ÉÏ£¬Ð»Ð»°¡£¡ ÏîÄ¿½éÉÜ£º ½ñÄêÒ»Ô·Ý,ÒÔÓ¢¹ú¿ËÀ¼·Æ¶ûµÂ´óѧ(Cranfield University)¡¢µÂ¹úÀ׸ù˹±¤´óѧ(University of Regensburg)¡¢ÈðÊ¿Áª°îÀí¹¤Ñ§Ôº(ETH Zurich)µÈÅ·Ã˵Ä12ËùÖøÃû´óѧÒÔ¼°ÊÀ½çÖøÃûµÄÂÞÊÏÖÆÒ©¹«Ë¾ÁªºÏÉêÇëµÄÅ·ÃËµÚÆß¿ò¼ÜÐÒéϵÄÂêÀö¾ÓÀïÐж¯¼Æ»®ÖеĴóÐ͹ú¼ÊÅàѵ¼Æ»®International Training Networks - Chemical Bioanalysis£¨¼ò³Æ£ºCHEBANA£©ÒÑ»ñÅú×¼£¬¸ÃÏîÄ¿ÊÇĿǰŷÃËÅú×¼µÄ×î´óµÄÒ»¸ö¹ú¼ÊºÏ×÷ÏîÄ¿£¬Ä¿µÄÔÚÓÚ´ÓÊÀ½ç¸÷¹úÑ¡°ÎÓÅÐãµÄ±¾¿ÆºÍ˶ʿ±ÏÒµÑо¿Éúµ½Å·Ã˵ÄÕâ12Ëù´óѧ¹¥¶Á²©Ê¿Ñо¿Éú£¬Ìṩ¸ß¶îµÄ½±Ñ§½ð£¬Á¬ÐøÌṩÈýÄ꣬×ÊÖúÆäÍê³É²©Ê¿Ñ§Î»£¬ÔÚ¹¥¶Á²©Ê¿Ñ§Î»ÆÚ¼ä£¬¸ù¾ÝÑо¿ÐèÒª£¬ÔÊÐí²©Ê¿Ñо¿Éúµ½Õâ12Ëù´óѧ¼°ÂÞÊϹ«Ë¾½øÐÐ¶ÌÆÚÑо¿£¬¼®´Ë½¨Á¢ÆðºÍÅ·ÖÞÉú»¯·ÖÎöÁìÓòÄڵĶ¥¼¶Ñо¿»ú¹¹½¨Á¢Æð³¤ÆÚµÄ¿ÆÑкÏ×÷¹ØÏµ¡£¸Ã½±Ñ§½ðÈ«³ÆÊÇÂêÀö¾ÓÀアѧ½ð£¬ËÄ´¨´óѧµÄÀîÓñ±¦½ÌÊÚÔøÄõ½¹ýÕâ¸ö½±Ñ§½ðÔÚºÉÀ¼µÄÀ³¶Ù´óѧȡµÃ²©Ê¿Ñ§Î»¡£¸Ã½±Ñ§½ð¿Û³ýѧ·ÑÍ⣬ÿÄê¿ÉÒÔ¾»Ê£Á½Íò¶àÅ·Ôª¡£ÓйظÃÏîÄ¿µÄÏà¹ØÁ´½ÓÈçÏ£ºhttp://www.chebana.eu/# ÏÖÏ£ÍûÕÐÊÕÒ»ÃûÀ´×Ô¹úÄÚ¸ßˮƽ´óѧµÄѧÉú£¬Ç°À´¹¥¶Á²©Ê¿Ñ§Î»¡£ ¾ßÌåÒªÇóÈçÏ£º 1£® ½ñÄê¾ÅÔ·ÝÈëѧ£¬ÈëѧǰÒÑ»ñµÃ˶ʿѧλ£¬Ó¢Óï´ïµ½Ó¢¹ú´óѧÈëѧµÄÌõ¼þ£¨ÑÅ˼6.5·Ö£¬ÖÁÉÙ6.0·Ö£¬»òÕßÓÐÏàÓ¦µÄÍи£³É¼¨ £©£» 2£® ÕýÔÚ´ÓÊ·Ö×ÓÓ¡¼£Ñ§¿ÆÁìÓòµÄÑо¿£¬ÒÔµÚÒ»×÷Õߣ¨º¬µ¼Ê¦µÚÒ»¡¢Ñ§ÉúµÚ¶þ£©ÔÚSCIÊÕ¼µÄ¹ú¼Ê¿¯ÎïÉÏ·¢±í¹ý·Ö×ÓÓ¡¼£ÎªÖ÷ÌâµÄÑо¿ÂÛÎÄ£»»òÕßËäδ´ÓÊ·Ö×ÓÓ¡¼£·½ÃæµÄÑо¿£¬µ«ÊDZ¾ÈËÓнÏÇ¿µÄÓлúºÏ³É±³¾°£¬ÒѾÔÚÏàÓ¦µÄÁìÓòÄÚÒ²ÒÔµÚÒ»×÷Õߣ¨º¬µ¼Ê¦µÚÒ»¡¢Ñ§ÉúµÚ¶þ£©ÔÚSCIÊÕ¼µÄ¹ú¼Ê¿¯ÎïÉÏ·¢±í¹ýÑо¿ÂÛÎÄ¡£ ¸½: Ó¢¹ú¿ËÀ¼·Æ¶ûµÂ´óѧ»ù±¾Çé¿ö£º ¿ËÀ¼·Æ¶ûµÂ´óѧÊÇÒ»ËùÉùÓþÈ«Çò¡¢Ñо¿ÐÍ£¨ÀàËÆÓÚÖйú¿ÆÑ§Ôº¡ª¡ªÖ»ÅàÑøÑо¿Éú¼°²©Ê¿Éú£©¡¢Ó¢¹úΨһÁ½´Î»ñµÃÅ®Íõ½±ÕµĴóѧ£¨Ñо¿ÊµÁ¦Î»¾ÓÓ¢¹úǰ10Ãû£©¡£ÆäËùÊôCranfield HealthÊǹú¼ÊÉúÎï´«¸Ðѧ¿ÆµÄ·¢Ô´µØ£¬ÊÇѧ¿Æµì»ùÈË¡¢ÉúÎï´«¸Ð´ó»áÖ÷ϯ¡¢Ó¢¹ú»Ê¼Ò»¯Ñ§»á»áÊ¿¡¢ÃÀ¹ú¹ú¼Ò¹¤³ÌԺԺʿ¡¢Biosensors & Bioelectronics (IF 5.429) Ö÷±àAnthony P.F. Turner½ÌÊÚµÄÈÎÖ°ËùÔڵء£¿ËÀ¼·Æ¶ûµÂ´óѧ½¡¿µÑ§ÔºÊÇÈ«Çò×î¾ßÓ°ÏìÁ¦µÄÉúÎï´«¸ÐÓë·Ö×ÓÓ¡¼£¼¼ÊõµÄ»ùµØÖ®Ò»¡¢ÊÇÊÀ½çÉϵÚÒ»¸öÉÌÒµ»¯ÆÏÌÑÌÇ´«¸ÐÆ÷µÄÆðÔ´µØ¡£½¡¿µÑ§ÔºÏÖÓµÓÐÄÉÃײÄÁϺÍÉúÎï´«¸ÐµÄÉè¼Æ¡¢ºÏ³ÉºÍÓ¦ÓÃËùÐèÒªµÄ¼¼ÊõʵÑéÊҺ͸÷ÖÖ±íÕ÷ÒÇÆ÷¡£¿ËÀ¼·Æ¶ûµÂ´óѧ½¡¿µÑ§Ôº×Ô³ÉÁ¢ÒÔÀ´£¬Ò»Ö±ÊÇÉúÎï´«¸ÐÁìÓòµÄÊÀ½ç°ÔÖ÷£¬ÔÚÉúÎï´«¸ÐºÍÖÇÄܲÄÁÏÇ°ÑØÑо¿ÁìÓòºÍÊÀ½ç¸÷µØÓÐ׏㷺µÄºÏ×÷£¬ÈçÔÚ·ðÂÞÂ×Èø´óѧ£¨University of Florence£©½¨Á¢ÁËÒ»¸ö³¤ÆÚµÄÉúÎï´«¸ÐʵÑéÊÒ¡£Õâ¸öÑо¿×éÒ²ºÍÊÀ½çÉÌÒµ¹«Ë¾½¨Á¢Á˹㷺µÄºÏ×÷ÈçPelikan Technologies (USA), SCA Group (Sweden), NEC Electronics (Europe), GmbH (Germany), Biosensia (Ireland), GSK (UK), Sphere Medical Limited (UK) and Akubio Ltd (UK) µÈ¡£ ѧԺËùÊôµÄÉúÎï´«¸ÐÖÐÐÄÊÇÊÀ½ç¼¶µÄÉúÎï´«¸ÐÖÐÐÄ£¬ÓµÓÐÒ»Ö§Ô¼40λѧÕß(ÆäÖÐ20λΪ¹ú¼ÊÖªÃûѧÕß) ×é³ÉµÄ¿ÆÑÐÍŶӡ£ÔÚ½üÊ®Äê·¢±íÁË220ƪ¸ßÓ°ÏìµÄ¿ÆÑÐÂÛÎĺͻñµÃ40ÏîÓ¦ÓÃרÀû£¬²¢hostÁËÈý¸öÅ·ÖÞÂêÀö¾ÓÀïѧÕߣ¨IIF£©¡£µ½Ä¿Ç°ÎªÖ¹£¬ÒѾºÍÊÀ½çÉϽ¨Á¢Á˳¤ÆÚµÄºÏ×÷ÈçUniversities of Florence (Italy), Lund (Sweden), Kalmar (Sweden), Verona (Italy), and Regensburg (Germany), ÒÔ¼°¹«Ë¾Èç Pelikan Technologies (USA), SCA Group (Sweden), NEC Electronics (Europe) GmbH (Germany), Biosensia (Ireland), GSK (UK), J&J, Sphere Medical Limited (UK) and Akubio Ltd (UK)µÈµÈ¡£ ÉúÎï´«¸ÐÖÐÐÄÖ÷ÈÎΪ¹ú¼ÊÖøÃûµÄ·Ö×ÓÓ¡¼£¼°ÉúÎï´«¸Ðѧר¼Ò Sergey A Piletsky½ÌÊÚ£¬ÊÇÓ¢¹ú»Ê¼Òѧ»áWolfson Research Merit ½±µÃÖ÷£¬´Ó2002Ä꿪ʼһֱµ£ÈÎÉúÎï´«¸ÐÖÐÐÄÖ÷ÈΡ£ Sergey A Piletsky½ÌÊÚÔÚÉúÎï´«¸ÐÁìÓò¹¤×÷³¬¹ý15Ä꣬²¢±à¼ÁËÒ»²¿ÓÐÃûµÄ·Ö×ÓÓ¡¼£¾ÛºÏÎïÊé(¡°Molecular Imprinting of Polymers¡±, Landes Bioscience, Georgetown, TX, USA, 2006)£¬³ö°æÁË200¶àƪѧÊõÂÛÎÄ£¬ÔÚ¸÷ÖÖ¹ú¼Ê»áÒéºÍ´óѧ½²×ù³¬¹ý60´Î,ÂÛÎÄ×ܼƱ»ÒýÓÃ4300¶à´Î£¬ H-IndexΪ36¡£ÔÚ¹ýÈ¥¼¸ÄêÀËûºÍTurner ½ÌÊÚÒ»ÆðÖ¸µ¼ÁË60Ãû²©Ê¿ÉúºÍ30¸ö²©Ê¿ºóÑо¿ÈËÔ±¡£ |
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©
» ²ÂÄãϲ»¶
ÉϺ£½»Í¨´óѧÄÉÃׯ÷¼þºÍ²ÄÁÏÑо¿×éÕÐÆ¸²©Ê¿Éú
ÒѾÓÐ1È˻ظ´
ÉϺ£½»Í¨´óѧÄÉÃׯ÷¼þºÍ²ÄÁÏÑо¿×éÕÐÆ¸½ÌʦºÍ²©Ê¿ºó
ÒѾÓÐ0È˻ظ´
°ëµ¼Ìå¿ÆÑ§ÓëÐÅÏ¢Æ÷¼þÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ204È˻ظ´
ɽ¶«´óѧÀàÄÔ¼ÆËãÓëÆ÷¼þ·½ÏòÕÐÊÕ2026Äê9ÔÂÈëѧµÄ²©Ê¿Ñо¿Éú
ÒѾÓÐ0È˻ظ´
µç¶Æ/µçÖýÄ£Äâ·ÖÎö
ÒѾÓÐ0È˻ظ´
ÉϺ£½»Í¨´óѧ¼¯³Éµç·ѧԺÄÉÃׯ÷¼þºÍ²ÄÁÏÑо¿×éÕÐÊÕ²©Ê¿Éú
ÒѾÓÐ0È˻ظ´
ÉϺ£½»Í¨´óѧ¼¯³Éµç·ѧԺÄÉÃׯ÷¼þºÍ²ÄÁÏÑо¿×éÕÐÆ¸½ÌʦºÍ²©Ê¿ºó
ÒѾÓÐ0È˻ظ´
¡¾CSC²©Ê¿ÕÐÉú¡¿Î÷°àÑÀCSIC¨CICMM | 2D²ÄÁÏ/Á¿×Óµç×Ó/ÈÈÊäÔË·½Ïò | 2025
ÒѾÓÐ0È˻ظ´
ÇóSOFCȼÁÏµç³ØµÄ»¯¹¤ÏµÍ³Á÷³ÌÉè¼ÆµÄ´óÉñÖ¸µã£¡
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
±¾¿Æ985µÄ»úеרҵ£¬Ë¶Ê¿Îªº½¿Õ·¢¶¯»ú£¬ÇóÍÆ¼öPhD
ÒѾÓÐ7È˻ظ´
ÓÐÈ¥cranfield ´óѧ£¿Ñ§engineering
ÒѾÓÐ4È˻ظ´
²©Ê¿±ÏÒµµÚÒ»¸ö²©ºó-²»×öʵÑé ×ö×ÉѯµÄpostdoc£¬ÇóÒÔºóÈçºÎ·¢Õ¹
ÒѾÓÐ17È˻ظ´
³ö¹úÉêÇë ÎÒµÄpotential supervisorÃûµ¥
ÒѾÓÐ13È˻ظ´
Ó¢¹ú·ÃÎÊѧÕßÒ»ÄêµÄ·ÑÓã¡
ÒѾÓÐ5È˻ظ´
¹ØÓÚ³ö¹úÁôѧ º½¿Õ·¢¶¯»úרҵ»òÕßµÍÎÛȾȼÉÕרҵµÄÅ·ÖÞѧУ
ÒѾÓÐ1È˻ظ´
¿ËÀ¼·Æ¶ûµÂ´óѧÕÐÉú
ÒѾÓÐ32È˻ظ´
Ó¢¹úCranfield´óѧ³ÏÕв©Ê¿Ñо¿Éú
ÒѾÓÐ1È˻ظ´
±»¾Üºó£¬Íâµ¼¸øµÄ»ØÐÅ
ÒѾÓÐ14È˻ظ´
¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
|
±¾ÌûÄÚÈݱ»ÆÁ±Î |
10Â¥2011-06-08 20:59:48
´ó¹ûÁ£tracy
ľ³æ (ÖøÃûдÊÖ)
- DIY-EPI: 2
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ¹ó±ö: 0.006
- ½ð±Ò: 2189.3
- É¢½ð: 193
- ºì»¨: 13
- Ìû×Ó: 1783
- ÔÚÏß: 444.9Сʱ
- ³æºÅ: 1181190
- ×¢²á: 2010-12-31
- רҵ: Éú»¯·ÖÎö¼°ÉúÎï´«¸Ð

2Â¥2011-06-02 10:19:40
ll8nol
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 328.7
- ºì»¨: 4
- Ìû×Ó: 193
- ÔÚÏß: 19.9Сʱ
- ³æºÅ: 884749
- ×¢²á: 2009-10-26
¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
|
²ËÄñ·É°¡~·É°¡~~·É¹ý~ ~ ~ »°ËµÂ¥Ö÷ÒÔºó¿ÉÒÔ·¢È¥ÕÐÆ¸°æÁË |
3Â¥2011-06-02 18:00:22
yetaieva
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 66 (³õÖÐÉú)
- ½ð±Ò: 7564
- É¢½ð: 1638
- ºì»¨: 15
- ɳ·¢: 1
- Ìû×Ó: 2846
- ÔÚÏß: 4341.1Сʱ
- ³æºÅ: 767047
- ×¢²á: 2009-05-10
- רҵ: ¹âÆ×·ÖÎö
¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
| »¹ÕæÓÐÕзÖ×ÓÓ¡¼£µÄ°¡£¬Ã÷Äê²Å±ÏÒµ¡£¡£¡£¡£²»ÖªµÀÃ÷Ä껹Õв» |
4Â¥2011-06-04 14:45:40













»Ø¸´´ËÂ¥
xgxofdream



